Columbia Laboratories Inc (CBRX)

6.19
1.76 22.14
NASDAQ : Health Care
Prev Close 7.95
Open 8.05
Day Low/High 6.17 / 8.10
52 Wk Low/High 5.09 / 15.44
Volume 155.03K
Avg Volume 58.70K
Exchange NASDAQ
Shares Outstanding 10.78M
Market Cap 79.30M
EPS 0.31
P/E Ratio 27.26
Div & Yield N.A. (N.A)

Latest News

Biotech Stocks Triggering Breakout Trades: Columbia Labs

Biotech Stocks Triggering Breakout Trades: Columbia Labs

Here's how to trade this under-$10 biotech stock.

Columbia Laboratories To Receive One-time Payment From Actavis For CRINONE U.S. Manufacturing Rights

Columbia Laboratories To Receive One-time Payment From Actavis For CRINONE U.S. Manufacturing Rights

Columbia Retains Royalty Right on U.S. CRINONE Sales

Columbia Laboratories Reports Third Quarter 2013 Financial Results

Columbia Laboratories Reports Third Quarter 2013 Financial Results

Management Will Host Conference Call at 11:00AM EST Today

Amended Class Action Lawsuit Against Columbia Laboratories Dismissed Without Prejudice

Amended Class Action Lawsuit Against Columbia Laboratories Dismissed Without Prejudice

Columbia Laboratories, Inc. (Nasdaq:CBRX) announced today that the previously disclosed Consolidated Second Amended Class Action Complaint to the putative class action lawsuit filed against the Company, Actavis, Inc.

Molecular Profiles Selected To Develop Topical & Oral Psoriasis Products For Telormedix

Molecular Profiles Selected To Develop Topical & Oral Psoriasis Products For Telormedix

Pharmaceutical formulation development and manufacturing services provider Molecular Profiles Ltd.

Columbia Laboratories Expands Board Of Directors

Columbia Laboratories Expands Board Of Directors

Columbia Laboratories, Inc. (Nasdaq:CBRX) today announced that its Board of Directors has appointed three experienced healthcare executives with over 65 years collective industry experience to its Board of Directors, ...

Columbia Laboratories Acquires Molecular Profiles Ltd., A U.K.-Based Provider Of Pharmaceutical Formulation Development And Manufacturing Services

Columbia Laboratories Acquires Molecular Profiles Ltd., A U.K.-Based Provider Of Pharmaceutical Formulation Development And Manufacturing Services

Columbia Laboratories Inc. (NasdaqCM:CBRX) [“Columbia”, the “Company”] has acquired Molecular Profiles Ltd.

Columbia Laboratories Regains Compliance With Nasdaq Listing Standards

Columbia Laboratories Regains Compliance With Nasdaq Listing Standards

Columbia Laboratories, Inc. (NasdaqCM:CBRX) received notice on August 23, 2012, from the Nasdaq Stock Market that the Company has regained compliance with the Nasdaq Stock Market minimum bid price requirement as set...

Columbia Laboratories Announces One-for-Eight Reverse Stock Split

Columbia Laboratories Announces One-for-Eight Reverse Stock Split

Columbia Laboratories, Inc. (“Columbia” or the “Company”) (NasdaqCM: CBRX) announced a 1-for-8 reverse split of its Common Stock, par value $0.

Columbia Laboratories Reports Second Quarter 2013 Financial Results

Columbia Laboratories Reports Second Quarter 2013 Financial Results

Columbia Laboratories, Inc. (NasdaqCM: CBRX) today reported financial results for the three and six-month periods ended June 30, 2013.

Columbia Laboratories’ Board Approves 1-for-8 Reverse Stock Split

Columbia Laboratories’ Board Approves 1-for-8 Reverse Stock Split

Columbia Laboratories, Inc. (“Columbia” or the “Company”) (NasdaqCM: CBRX) announced today that its Board of Directors (the “Board”) has set a ratio of 1-for-8 for its previously approved...

Columbia Laboratories To Discuss Second Quarter 2013 Financial Results On August 7 Conference Call

Columbia Laboratories To Discuss Second Quarter 2013 Financial Results On August 7 Conference Call

Columbia Laboratories, Inc. (NasdaqCM: CBRX) will hold a conference call on August 7, 2013, to discuss financial results of the second quarter ended June 30, 2013.